Serologische und klinische daten weisen auf das endemische vorkommen der humanen granulozytaren ehrlichiose in der nordostschweiz hin

Translated title of the contribution: Serological and clinical evidence for human granulocytic ehrlichiosis in north-eastern Switzerland

R. Weber, Nicola Pusterla, M. Loy, C. M. Leutenegger, G. Schar, D. Baumann, C. Wolfensberger, H. Lutz

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Tick-borne human granulocytic ehrlichiosis (HGE) has not been diagnosed in Switzerland, although the HGE agent has been identified in ticks and animal reservoirs and human infections have been suspected on the basis of serological surveys. Methods: We retrospectively tested sera of 48 persons with antibodies to B. burgdorferi and/or tick-borne encephalitis virus for the presence of antibodies to E. phagocytophila (a surrogate marker of the agent of HGE), and reviewed their charts with regard to clinical manifestations possibly associated with a tickborne infection. We then prospectively examined EDTA blood of 80 patients who presented with fever to 21 days after a tick bite for the presence of the HGE agent (using nested PCR and microscopic examination of blood smears) and anti-E. phagocytophila antibodies. We also collected clinical data. Results: The retrospective study revealed 12 persons (25%) with anti-E. phagocytophila antibody titers ≥1:80, suggesting coinfection with HGE and either Lyme Borrelia or tickborne encephalitis virus. Among these, 7 patients presented with clinical manifestations compatible with HGE disease. The prospective investigation identified patients (10%) with anti-E. phagocytophila antibody titers ≥1:80, and 7 of these presented with signs and symptoms sUggeSting HGE. The HGE agent, however, was detected neither by PCR nor by microscopic examination. Conclusions: Serological and clinical data suggest the occurrence of an HGE-like agent as well as of coinfections with HGE and B. burgdorferi or tick-borne encephalitis virus in Switzerland. However, the HGE agent was not identified in persons living in Switzerland.

Original languageGerman
Pages (from-to)1462-1470
Number of pages9
JournalSchweizerische Medizinische Wochenschrift
Volume130
Issue number41
StatePublished - Oct 14 2000
Externally publishedYes

Fingerprint

Ehrlichiosis
Switzerland
Antibodies
Tick-Borne Encephalitis Viruses
Ticks
Coinfection
Encephalitis Viruses
Tick Bites
Borrelia
Polymerase Chain Reaction
Infection
Edetic Acid
Signs and Symptoms

Keywords

  • Human granulocytic ehrlichiosis
  • Switzerland
  • Tick-borne diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Serologische und klinische daten weisen auf das endemische vorkommen der humanen granulozytaren ehrlichiose in der nordostschweiz hin. / Weber, R.; Pusterla, Nicola; Loy, M.; Leutenegger, C. M.; Schar, G.; Baumann, D.; Wolfensberger, C.; Lutz, H.

In: Schweizerische Medizinische Wochenschrift, Vol. 130, No. 41, 14.10.2000, p. 1462-1470.

Research output: Contribution to journalArticle

Weber, R, Pusterla, N, Loy, M, Leutenegger, CM, Schar, G, Baumann, D, Wolfensberger, C & Lutz, H 2000, 'Serologische und klinische daten weisen auf das endemische vorkommen der humanen granulozytaren ehrlichiose in der nordostschweiz hin', Schweizerische Medizinische Wochenschrift, vol. 130, no. 41, pp. 1462-1470.
Weber, R. ; Pusterla, Nicola ; Loy, M. ; Leutenegger, C. M. ; Schar, G. ; Baumann, D. ; Wolfensberger, C. ; Lutz, H. / Serologische und klinische daten weisen auf das endemische vorkommen der humanen granulozytaren ehrlichiose in der nordostschweiz hin. In: Schweizerische Medizinische Wochenschrift. 2000 ; Vol. 130, No. 41. pp. 1462-1470.
@article{07f45068662845879eba75b7b9ee0989,
title = "Serologische und klinische daten weisen auf das endemische vorkommen der humanen granulozytaren ehrlichiose in der nordostschweiz hin",
abstract = "Background: Tick-borne human granulocytic ehrlichiosis (HGE) has not been diagnosed in Switzerland, although the HGE agent has been identified in ticks and animal reservoirs and human infections have been suspected on the basis of serological surveys. Methods: We retrospectively tested sera of 48 persons with antibodies to B. burgdorferi and/or tick-borne encephalitis virus for the presence of antibodies to E. phagocytophila (a surrogate marker of the agent of HGE), and reviewed their charts with regard to clinical manifestations possibly associated with a tickborne infection. We then prospectively examined EDTA blood of 80 patients who presented with fever to 21 days after a tick bite for the presence of the HGE agent (using nested PCR and microscopic examination of blood smears) and anti-E. phagocytophila antibodies. We also collected clinical data. Results: The retrospective study revealed 12 persons (25{\%}) with anti-E. phagocytophila antibody titers ≥1:80, suggesting coinfection with HGE and either Lyme Borrelia or tickborne encephalitis virus. Among these, 7 patients presented with clinical manifestations compatible with HGE disease. The prospective investigation identified patients (10{\%}) with anti-E. phagocytophila antibody titers ≥1:80, and 7 of these presented with signs and symptoms sUggeSting HGE. The HGE agent, however, was detected neither by PCR nor by microscopic examination. Conclusions: Serological and clinical data suggest the occurrence of an HGE-like agent as well as of coinfections with HGE and B. burgdorferi or tick-borne encephalitis virus in Switzerland. However, the HGE agent was not identified in persons living in Switzerland.",
keywords = "Human granulocytic ehrlichiosis, Switzerland, Tick-borne diseases",
author = "R. Weber and Nicola Pusterla and M. Loy and Leutenegger, {C. M.} and G. Schar and D. Baumann and C. Wolfensberger and H. Lutz",
year = "2000",
month = "10",
day = "14",
language = "German",
volume = "130",
pages = "1462--1470",
journal = "Schweizerische Medizinische Wochenschrift",
issn = "0036-7672",
publisher = "EMH Swiss Medical Publishers Ltd.",
number = "41",

}

TY - JOUR

T1 - Serologische und klinische daten weisen auf das endemische vorkommen der humanen granulozytaren ehrlichiose in der nordostschweiz hin

AU - Weber, R.

AU - Pusterla, Nicola

AU - Loy, M.

AU - Leutenegger, C. M.

AU - Schar, G.

AU - Baumann, D.

AU - Wolfensberger, C.

AU - Lutz, H.

PY - 2000/10/14

Y1 - 2000/10/14

N2 - Background: Tick-borne human granulocytic ehrlichiosis (HGE) has not been diagnosed in Switzerland, although the HGE agent has been identified in ticks and animal reservoirs and human infections have been suspected on the basis of serological surveys. Methods: We retrospectively tested sera of 48 persons with antibodies to B. burgdorferi and/or tick-borne encephalitis virus for the presence of antibodies to E. phagocytophila (a surrogate marker of the agent of HGE), and reviewed their charts with regard to clinical manifestations possibly associated with a tickborne infection. We then prospectively examined EDTA blood of 80 patients who presented with fever to 21 days after a tick bite for the presence of the HGE agent (using nested PCR and microscopic examination of blood smears) and anti-E. phagocytophila antibodies. We also collected clinical data. Results: The retrospective study revealed 12 persons (25%) with anti-E. phagocytophila antibody titers ≥1:80, suggesting coinfection with HGE and either Lyme Borrelia or tickborne encephalitis virus. Among these, 7 patients presented with clinical manifestations compatible with HGE disease. The prospective investigation identified patients (10%) with anti-E. phagocytophila antibody titers ≥1:80, and 7 of these presented with signs and symptoms sUggeSting HGE. The HGE agent, however, was detected neither by PCR nor by microscopic examination. Conclusions: Serological and clinical data suggest the occurrence of an HGE-like agent as well as of coinfections with HGE and B. burgdorferi or tick-borne encephalitis virus in Switzerland. However, the HGE agent was not identified in persons living in Switzerland.

AB - Background: Tick-borne human granulocytic ehrlichiosis (HGE) has not been diagnosed in Switzerland, although the HGE agent has been identified in ticks and animal reservoirs and human infections have been suspected on the basis of serological surveys. Methods: We retrospectively tested sera of 48 persons with antibodies to B. burgdorferi and/or tick-borne encephalitis virus for the presence of antibodies to E. phagocytophila (a surrogate marker of the agent of HGE), and reviewed their charts with regard to clinical manifestations possibly associated with a tickborne infection. We then prospectively examined EDTA blood of 80 patients who presented with fever to 21 days after a tick bite for the presence of the HGE agent (using nested PCR and microscopic examination of blood smears) and anti-E. phagocytophila antibodies. We also collected clinical data. Results: The retrospective study revealed 12 persons (25%) with anti-E. phagocytophila antibody titers ≥1:80, suggesting coinfection with HGE and either Lyme Borrelia or tickborne encephalitis virus. Among these, 7 patients presented with clinical manifestations compatible with HGE disease. The prospective investigation identified patients (10%) with anti-E. phagocytophila antibody titers ≥1:80, and 7 of these presented with signs and symptoms sUggeSting HGE. The HGE agent, however, was detected neither by PCR nor by microscopic examination. Conclusions: Serological and clinical data suggest the occurrence of an HGE-like agent as well as of coinfections with HGE and B. burgdorferi or tick-borne encephalitis virus in Switzerland. However, the HGE agent was not identified in persons living in Switzerland.

KW - Human granulocytic ehrlichiosis

KW - Switzerland

KW - Tick-borne diseases

UR - http://www.scopus.com/inward/record.url?scp=0034649107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034649107&partnerID=8YFLogxK

M3 - Article

C2 - 11075410

AN - SCOPUS:0034649107

VL - 130

SP - 1462

EP - 1470

JO - Schweizerische Medizinische Wochenschrift

JF - Schweizerische Medizinische Wochenschrift

SN - 0036-7672

IS - 41

ER -